Dr Reddy’s, GARDP get Thai FDA’s nod for Nuzolvence

thehindubusinessline.com · 2026-07-27

The Thai FDA approval comes just six months after the drug was initially approved by the United States Food and Drug Administration, making Thailand the second country to approve the drug

TickrTrends take: Innoviva Inc (INVA) operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends. While the headline concerns Dr Reddy's and GARDP receiving Thai FDA approval for Nuzolvence, investors should monitor whether such regulatory developments in antibiotic treatments create competitive pressures or partnership opportunities that could affect INVA's market position and asset valuation. The healthcare regulatory environment remains dynamic, and approval timelines for similar therapeutics may influence sector-wide valuation multiples that could eventually impact fairly valued assessments.

Read the full story at thehindubusinessline.com →